People researching growth-hormone-related peptides often compare sermorelin vs ipamorelin vs tesamorelin side by side. This guide explains how they actually differ — in plain terms — and why “which is best” is a question for a licensed provider, not a ranking chart.
The short version
All three relate to the growth-hormone system, but they are distinct compounds that work differently:
- Sermorelin — a growth-hormone-releasing-hormone (GHRH) analog. It signals the pituitary gland through the GHRH receptor to release the body’s own growth hormone. The sermorelin prescribed today is a compounded medication, not an FDA-approved finished product. See the sermorelin treatment page.
- Ipamorelin — a growth-hormone secretagogue that acts through a different receptor pathway (the ghrelin / GH-secretagogue receptor) rather than the GHRH receptor.
- Tesamorelin — a distinct, more potent GHRH analog that carries its own FDA-approved indication in a specific clinical context.
Why the mechanism difference matters
Because sermorelin and ipamorelin act through different receptors, they are not simply stronger-or-weaker versions of the same thing — they are different tools. Tesamorelin, while in the GHRH-analog family like sermorelin, is a separate medication with its own approval and profile. None of these are interchangeable, and the differences are exactly why a clinical evaluation matters.
”Which is best?” is the wrong question
A lot of online content ranks these peptides as if one wins for everyone. That framing is misleading. Appropriateness depends on the individual — health history, goals, contraindications, and a provider’s clinical judgment. There is no universal best.
What about combining them?
You will sometimes see “sermorelin + ipamorelin” discussed as a stack. Combining prescription medications is a clinical decision only a licensed provider can make and is never something to self-direct. If a provider determines a particular approach is appropriate for you, they prescribe and supervise it.
The bottom line
Comparing peptides is useful for understanding, but the decision is clinical. If you are considering sermorelin specifically, the next step is an evaluation — not a comparison chart.
Want to know if sermorelin fits your situation? Start a clinical evaluation with REMEVi — a licensed US provider reviews your case before anything is prescribed. $145 for a 4-week subscription, bilingual care.
Related reading: sermorelin benefits and sermorelin dosage.
This article is for general education and is not medical advice. Sermorelin is a non-FDA-approved compounded medication available only by prescription from a licensed provider after an individual evaluation.
Frequently asked questions
What is the difference between sermorelin and ipamorelin?
They act on the growth-hormone pathway through different mechanisms. Sermorelin is a growth-hormone-releasing-hormone (GHRH) analog that signals the pituitary through the GHRH receptor. Ipamorelin is a growth-hormone secretagogue that works through a different (ghrelin/GH-secretagogue) receptor. They are sometimes discussed together, but they are distinct compounds, and which — if either — is appropriate is a clinical decision a licensed provider makes.
What is the difference between sermorelin and tesamorelin?
Both are GHRH-related peptides, but tesamorelin is a distinct, more potent GHRH analog that carries its own FDA-approved indication in a specific clinical context, while the sermorelin prescribed today is a compounded medication. They are not interchangeable, and only a licensed provider can determine what is appropriate for an individual.
Is one of them better than the others?
There is no universal 'best' — these are different compounds with different properties, and appropriateness depends entirely on the individual patient and clinical judgment. Marketing that ranks them as if one wins for everyone is oversimplifying. A licensed provider evaluates your situation.
Can sermorelin and ipamorelin be combined?
You may see them discussed as a combination online, but combining prescription medications is strictly a clinical decision. It is not something to self-direct. A licensed provider determines whether any single peptide or combination is appropriate, and at what dose.
Which one does REMEVi prescribe?
REMEVi prescribes sermorelin as part of its cellular program, when a licensed provider determines it is clinically appropriate after an individual evaluation. See the sermorelin treatment page for details.
